行情

HTGM

HTGM

HTG Molecular
NASDAQ

实时行情|Nasdaq Last Sale

0.2900
-0.0010
-0.34%
盘后: 0.2700 -0.02 -6.90% 18:50 04/03 EDT
开盘
0.2960
昨收
0.2910
最高
0.3030
最低
0.2671
成交量
83.20万
成交额
--
52周最高
3.240
52周最低
0.2671
市值
1,693.72万
市盈率(TTM)
-0.5042
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测HTGM价格均价为1.550,最高价位2.000,最低价为0.7000。

EPS

HTGM 新闻

更多
  • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Are Way More Bearish Than They Used To Be
  • Simply Wall St. · 4天前
  • Edited Transcript of HTGM earnings conference call or presentation 25-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 03/28 02:38
  • HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/26 03:05
  • HTG Molecular EPS beats by $0.02, revenue in-line
  • seekingalpha · 03/26 01:03

所属板块

先进医疗设备和技术
-1.50%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

HTGM 简况

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.
展开

微牛提供HTG Molecular Diagnostics Inc(NASDAQ-HTGM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的HTGM股票新闻,以帮助您做出投资决策。